BioSpace News Archive

CytoSorbents Corporation today reported unaudited financial and operating results for the quarter ended September 30, 2022.

Prothena Corporation plc today reported financial results for the third quarter and first nine months of 2022 and provided a business update.

Silk Road Medical, Inc. announced that management will present at the following investor conferences.

Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the third quarter ended September 30, 2022.

Cidara Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2022 and provided an update on its corporate activities and product pipeline.

RAM Medical Corporation L.L.C., based in UAE and Germany, has recently set up its headquarters in Dubai.

IVERIC bio, Inc. announced that it has submitted to the U.S. Food and Drug Administration the first part of its New Drug Application for rolling review of avacincaptad pegol a novel investigational complement C5 inhibitor, for the treatment of geographic atrophy secondary to Age-Related Macular Degeneration.

Neurosteer Inc. announced the FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform.

Willow Biosciences Inc. has released its financial and operating results for the three and nine months ended September 30, 2022, reporting significant progress to its operational platform, leadership and strong liquidity.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) announced today that the Food and Drug Administration (FDA) granted the RECELL System designations as a Breakthrough Device for its proposed soft tissue repair indication as well as its vitiligo indication.